A B S T R A C T Previous studies showed hyperresponsiveness to human growth hormone (hGH) in men with myotonic or limb girdle dystrophies (MMD or LGD). Because polyamines may mediate some actions of hGH, we have nlow investigated polyamine metabolisimi in these and other dystrophies.
INTRODUCTION
In subjects with growth hormonie (GH)l deficiency, injectioni of humani GH (hGH) causes retention of N, P, and K (1, 2) . The positive balances of these elemenits reflect expansion of the intracellular comiipartmienit with concomitant acceleration of protein synthesis. In normal individuals, any such effect at a given dose of hGH is <10% as great as in GH-deficienit indivi(luals (1) . Thus the latter patients are hyperresponsive to the anabolic effect of the hormnonie.
The mechanism by which GH stimnulates protein synthesis probably involves the polvamiiines putrescine (Pu), spermidine (Sd) , and sperminie (Sm), located in ribosomes and cytosol of all body cells in the form of polyamine-RNA (3, 4) and possibly polyamine-protein ' Abbreviations used in this paper: BW, body weight; Cd, cadaverine; DMD, Duchenne muscular dystrophy; GH, growth hormone; hGH, human GH; LGD, limb girdle muscular dystrophy; MMD, myotonic muscular dystrophy; Pu, putrescine; Sd, spermidine; Sm, spermine. (3, 12) . In GH-deficient subjects, polyamines in serum and urine are subnormal, and are restored to normal by hGH (13) . The hormone has little or no effect on polyamine levels in normal individuals. Men with myotonic and limb girdle muscular dystrophies (MMD and LGD) are hyperresponsive to the anabolic action of hGH, although they are not deficient in the endogenous hormone (1, 14) . The mechanism for this hyperresponsiveness, which is comparable to that of GH-deficient subjects, is not known, but it could involve the polyamines. To investigate this possibility, we measured polyamines in the serum and urine of men with MMD and LGD, before and during hGH treatment. Elemental balances were also determined. The same experiments were done in normal agematched men as controls.
Boys with Duchenne muscular dystrophy (DMD) do not show anabolic hyperresponsiveness to hGH (15 Table I . measurement of Pu, Sd, Sm, and Cd (13); fasting serum levels Metabolic balance studies were performed (1) . After a 3-d of these compounds were determined (13) on the last 2 d of equilibration to the standard diet, daily balances of N, P, and control and hGH periods. Urine from the boys with DMD and K were measured during a 5-d control period followed by a the normal boys was collected while they were on an ad lib. 5 University's Clinical Trials Commllittee and with the informed consent of subject or parents, as appropriate.
Dystrophic and normal male mice (strain 129/ReJ-dy), age 10 wk, were obtained from The Jackson Laboratory, Bar Harbor, Maine, and fed Purina rat chow (Ralston Purina Co., St. Louis, Mo.) ad lib. They were killed by decapitation; polyamines (16) and total N (17) were measured in a pool of three thigh muscles (vastus lateralis, vastus intermedius, rectus femoris), liver, kidney, and brain. Similar studies were done in dystrophic (Bio 14, 6) and control male hamsters, age 1-50 wk, obtained from BioResearch Consultants, Cambridge, Mass., and fed Purina rat chow ad lib. In addition to polyamines and N, P (18) and K (19) were also determined in the hamster thigh muscles.
Statistical methods. A single-factor repeated measures analysis was performed on each of the dependent variables (AN, AP, AK, urine and plasma polyamines). The grouping factor consisted of the normals (six), the MMD (four), and the LGD (three), over 10 timed periods (five before hGH treatment and five during hGH treatment). Five multiple comparisons were made in each analysis using the Bonferonni procedure. Standard errors for each comparison were estimated using the appropriate error term from the analyses of variance (see Fig. 1 and Tables II and III). A two-factor analysis of variance was performed for each muscle polyamine in the hamster. The factors were the groups (normal and dystrophic) and time in weeks. The average value for each group was then compared at each time period (Fig.  2) In the normal men, serum and urine Pu, Sd, and Sm levels fell within the 95% prediction limits reported for normal age-adjusted subjects (13) . The normal ranges of serum and urine Cd levels, not previously reported, were now found to be 0.00-0.02 ,mol/liter and 0.08-0.20 ,mol/kg BW per 24 h, respectively. The balances of N, P, and K were close to zero. During occurred in N, P, or K balance (confirming previous reports [1, 2] ) or in serum and urine polyamine levels.
In the four men with MMD, serum and urine polyamine profiles differed from the normal controls in this study and in previously reported experiments (13) . In serum and urine, Sm and Cd were significantly elevated (P < 0.005) and Sd was significantly depressed (P < 0.05). The degrees of elevation above the normal mean were twofold or more. Elemental balances during the control period were essentially zero. During treatment with hGH, serum and urine Pu, Sm, and Cd increased two-to threefold (P < 0.05), only Sd remaining unchanged. N, P, and K were retained in significant amounts, the ratios averaging 0.66 g/0.057 g/2.55 meq (confirming previous studies [1, 2] ).
In the three men with LGD, the basal levels of Sd, Sm, and Cd were all elevated in serum and urine (P < 0.005). Elemental balances before hGH treatment were close to zero. During hGH treatment, serum and urine levels of Pu, Sd, Sm, and Cd increased two-to threefold (P < 0.005); N, P, and K were retained in significant amounts [average, 0.61 g/0.057 g/2.46 meq], confirming an earlier study (14) .
Polyamine means in histologically dystrophic muscle from three men with LGD were markedly higher (P < 0.05) than in histologically normal muscle from five men of similar age (Table IV) .
DMD vs. normal boys (Table V) . The normal serum and urine levels of Pu, Sd, and Sm conformed to the previously described normal range (13) . Normal levels of Cd in serum and urine were: 0.00-0.02 ,umol/liter and 0.17-0.93 ,mol/kg per BW per 24 h, respectively.
In boys with DMD, serum and urine polyamine levels showed no significant differences from normal. Dystrophic vs. normal mice. Polyamines in liver, kidney, and brain did not differ between the two groups ( Table IV) . In dystrophic skeletal muscle, polyamines were significantly higher than in normal muscle (P < 0.05), whereas concentration of total N was not statistically different.
Diystrophic vs. niormal hamsters. At 14 wk, levels of polyamines in liver, kidney, and brain were not significantly different between the two groups (Table IV) . In dystrophic thigh muscles, all four polyamines were significantly elevated, whereas concentrations of N, P, and K were not statistically different from normal (data for P and K not shown).
Muscle polyamines were then measured in both groups at 1, 6, 19, and 30 wk (Fig. 2) . In normals, Pu, Sd, and Sm declined with age. In contrast, Cd rose to a peak at 11 wk, then declined slightly. A similar but less pronounced pattern was found in the dystrophic hamsters. At 1 wk, muscle polyamine levels were similar to normal. At all ages after 6 wk, the Pu, Sd, and Sm values, although declining with age (with the exception of Pu at 6 wk), remained significantly higher than normal (P < 0.05). Although Pu nearly disappeared from normal muscle after 6 wk, it persisted at an average of20-40 nmol/g wet tissue in dystrophic muscle. In the latter tissue, the level of Cd was significantly higher than normal after 11 wk (P < 0.05).
DISCUSSION
Before hGH treatment, the levels of polyamines in serum and urine in MMD and LGD differed from normal and from each other. In MMD, serum and urine Sd and Cd levels were elevated and Sm was depressed; in LGD, the levels of nearly all the polyamines (except serum Pu) were increased. An additional abnormality in polyamine metabolism of MMD and LGD became apparent during hGH treatment. Although the hormone caused no change in serum or urine polyamine levels in normals, in men with MMD and LGD it produced significant increases in all polyamines, except Sd in MMD.
Further evidence for abnormal polyamine metabolism in LGD was provided by the muscle analyses, which showed elevations comparable to those in serum and urine. This comparison is not definitive because only three LGD specimens were studied. However, a conclusive demonstration of elevated polyamines in two types of genetically dystrophic skeletal muscle was observed in the mouse and hamster. In both forms ofrodent dystrophy, the difference in polyamine profile between diseased and normal muscle generally resembled that between LGD and normal muscle of man. In both rodents, the polyamine profile remained normal in liver, kidney, and brain. The pathologic accumulation of polyamines in dystrophic hamster muscle began between 1 and 6 wk after birth and thereafter persisted or intensified with age.
How is the polyamine abnormality in men with Alternatively, a polyamine abnormality could be the cause and hyperresponsiveness to hGH could be the effect. Such a primary disorder in polyamine metabolism could be any of the following: (a) overactivity in one or more enzymes of polyamine biosynthesis (4, 22) ; (b) deficient activity in enzyme(s) responsible for oxidizing (4, 22) or conjugating the polyamines (23); (c) augmented binding of polyamines by cytoplasmic proteins or RNA (3, 5) . Then the observed increased basal levels of polyamines would result. Furthermore, because polyamines may be the intracellular mediators for some of the anabolic actions of GH (4), the accumulation of polyamines might cause the muscle cells to be hyperresponsive to exogenous hGH. Females with MMD and normal menstrual function do not exhibit anabolic hyperresponsiveness to hGH, apparently because endogenous estrogens inhibit this reaction to the hormone (2). It will be ofinterest to study serum and urine polyamines in such women before and during hGH treatment.
After the completion of this study, data on Pu, Sd, and Sm in skeletal muscle of dystrophic mice and patients were published by Kremzner et al. (24) . They found accumulations of polyamines in dystrophic mouse muscle at 1.5-8 wk generally similar to those reported here at 10 wk. In two of three cases of LGD, muscle Pu and Sd levels were reported by Kremzner et al. (24) to be higher than in controls; muscle Pu, Sd, and Sm levels in MMD were stated to be within the normal range. Ages of patients and controls, however, were not given, and it is not clear whether these groups were age matched. In view of the age dependence of polyamines in hamster (Fig. 2) and rat (25) , our data on muscle polyamines in 30-44 yr-old men without muscle disease and with LGD or MMD cannot readily be compared with those of Kremzner and co-workers (24) in subjects of unstated age.
